Impact of metastases location on mCRPC treatment selection

Jingsong Zhang, MD, PhD is a genitourinary oncologist at Moffitt Cancer Center and an assistant professor of oncology and internal medicine at the University of South Florida College of Medicine, discusses how the site of metastases impacts his approach to treatment selection for patients with metastatic castration-resistant prostate cancer.